Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Sue Erickson-Viitanen
Sustained-Release Ruxolitinib: Findings From a Phase 1 Study in Healthy Subjects and a Phase 2 Study in Patients With Myelofibrosis
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Related publications
The Clinical Benefit of Ruxolitinib Across Patient Subgroups: Analysis of a Placebo-Controlled, Phase III Study in Patients With Myelofibrosis
British Journal of Haematology
Hematology
Results of a Phase 2 Study of Pacritinib (SB1518), a JAK2/JAK2(V617F) Inhibitor, in Patients With Myelofibrosis
Blood
Biochemistry
Immunology
Cell Biology
Hematology
A Phase 2 Study of Simtuzumab in Patients With Primary, Post-Polycythaemia Vera or Post-Essential Thrombocythaemia Myelofibrosis
British Journal of Haematology
Hematology
Inhalation of a Dry Powder Ciprofloxacin Formulation in Healthy Subjects: A Phase I Study
Clinical Drug Investigation
Medicine
Pharmacology
Phase 1 Study of Crisaborole in Japanese Healthy Volunteers and Patients With Atopic Dermatitis
Journal of Dermatology
Dermatology
Medicine
Effect of Diet on Serum Creatinine in Healthy Subjects During a Phase I Study
Journal of Clinical Medicine Research
A Phase 2 and Biomarker Study of Cabozantinib in Patients With Advanced Cholangiocarcinoma
Cancer
Cancer Research
Oncology
Release Characteristics of Nifedipine Sustained-Release Granules in Vitro and in Healthy Subjects.
Chemical and Pharmaceutical Bulletin
Medicine
Drug Discovery
Chemistry
Carfilzomib Monotherapy in Japanese Patients With Relapsed or Refractory Multiple Myeloma: A Phase 1/2 Study
Cancer Science
Cancer Research
Medicine
Oncology